Previous 10 | Next 10 |
home / stock / pfe / pfe articles
AstraZeneca Plc’s (NASDAQ:AZN) Chief Executive Pascal Soriot says the company achieved a significant milestone by reaching a s...
Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) did not only earn billions of dollars from their COVID-19 leading products but also rose to fame for ...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Core & Main, Inc. (NYSE: CNM) is "right at the heart of this infr...
An investigational gene therapy, dubbed scAAV9/JeT-GAN, for a rare neurodegenerative disease, giant axonal neuropathy (GAN), that begins in early c...
Money manager Cathie Wood’s Ark Invest has a favorite biotech holding now, going by the firm’s recent buying activity. What Happened: A...
BioNTech SE (NASDAQ: BNTX) is way past its glorious Covid-19 days, when it thrived with Pfizer Inc (NYSE: PFE) for saving the world from the pandem...
Pfizer Inc’s (NYSE:PFE) German partner, BioNTech SE (NASDAQ:BNTX), reported fourth-quarter 2023 EPS of fiscal year Q4 GAAP EPS of €1.90 ...
Pfizer Inc (NYSE:PFE) plans to slash its stake to approximately 24% in Consumer healthcare giant Haleon Plc (NYSE:HLN)&nbs...
Thursday, Immuneering Corporation (NASDAQ:IMRX) revealed topline results from the ongoing Phase 1 portion of its Phase 1/2a trial of IMM-...
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 06:28:00 ET Pfizer (NYSE: PFE) can be a polarizing stock to own right now. Its future remains hazy given that it is facing some troubling patent cliffs and revenue from its COVID-19 vaccine is dwindling. But at the same time, the shares look cheap, and they could possess ...
2024-07-01 10:48:00 ET It's been a big year for most stocks, with the S&P 500 index up about 24% over the past 12 months. A rising market is wonderful for the stocks already in your portfolio, but finding new investment opportunities is a lot more challenging than it was a year ago....
Pfizer Inc. (NYSE: PFE) today announced the election of Cyrus Taraporevala to its Board of Directors, effective immediately. Mr. Taraporevala, age 57, was also appointed to and will join the Audit Committee and Compensation Committee of Pfizer’s Board. Mr. Taraporevala served as Presid...